P-583 Clinical parameters predictive of response in advance non-small-cell lung cancer (NSCLC) patients receiving gefitinib in am expanded access program (EAP) after failure of chemotherapy
Tibaldi, C., Vasile, E., Chella, A., Russo, E., Bernardini, I., Nacci, A., Falcone, A.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81076-1
Date:
July, 2005
File:
PDF, 293 KB
english, 2005